We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Health Canada Finalizes Recommendations on Third-Party Data in Drug Submissions
Health Canada Finalizes Recommendations on Third-Party Data in Drug Submissions
Sponsors seeking Canadian approval of new drugs or indications based on published literature or postmarketing data need to be able to prove that their drug is comparable to its reference product, regulators says.